Exosome-Based Targeted Drug Delivery Systems: Current Advances and Challenges
Abstract
Exosomes are naturally occurring nanovesicles (30–150nm) that serve as biological carriers for the targeted delivery of medicinal substances. Their membrane composition facilitates passage over physiological barriers, such as the blood-brain barrier, and offers good compatibility with bodily tissues. Using methods like electroporation, incubation, and donor-cell modification, therapeutic substances including medications, proteins, and genetic elements can be integrated into these vesicles. Selective contact with sick cells is enhanced by surface functionalization. By improving targeted medication delivery and lowering undesirable systemic exposure, these vesicles have demonstrated promise uses in the treatment of neurological diseases and cancer. Particle size, zeta potential, encapsulation efficiency, release kinetics, cellular uptake, stability, and targeting capability are all evaluated when characterizing exosome formulations. Notwithstanding these benefits, a number of challenges still exist, such as inconsistent isolation protocols, low loading efficiency, instability associated with storage, and challenges in large-scale production. Future applications of vesicle engineering and manufacturing technologies in precision-focused medicinal delivery systems may benefit from ongoing advancements in these fields.